Dr. Linda Mah is a Clinician Scientist at the Rotman Research Institute, Baycrest Health Sciences, an Associate Professor in Psychiatry, Division of Geriatric Psychiatry at the University of Toronto, and an Associate Member of the Institute of Medical Science, Faculty of Medicine, University of Toronto. Dr. Mah obtained her MD at the University of Calgary and completed a psychiatric residency at McGill University, followed by clinical neuropsychiatry specialty training at the University of Massachusetts and formal research training in cognitive and affective neurosciences at the National Institutes of Health, Bethesda, Maryland, USA. She has a Master of Health Sciences degree from Duke University, USA.
Dr. Mah’s research program focuses on understanding the relationship between cognition and emotion and their neuroanatomical correlates in healthy aging and in disorders of the elderly, including late-life depression (LLD), mild cognitive impairment (MCI), and Alzheimer’s disease (AD). Her research employs converging methods including behavioural paradigms, neuropsychological assessment, neuroimaging, and more recently, psychophysiology. She has a particular interest in examining emotion dysregulation and other neuropsychiatric symptoms as potential biomarkers of AD risk, and in understanding the link between stress and development of AD. Dr. Mah is also the PI or site PI on clinical trials focused on treatment-refractory depression in older adults and studies using brain stimulation as an intervention for cognitive decline in older adults at risk for developing AD, including those with remitted depression, subjective cognitive decline (SCD) or MCI.
Dr. Mah’s work has been funded by the Alzheimer’s Society of Canada, Brain Canada, and the Centre for Aging and Brain Health Innovation. She is an Associate Editor for the Journal of Alzheimer’s Disease.